BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8882899)

  • 1. Synthesis and biological evaluation of imidazole based compounds as cytochrome P-450 inhibitors.
    Ahmed S; Smith JH; Nicholls PJ; Whomsley R; Cariuk P
    Drug Des Discov; 1995 Aug; 13(1):27-41. PubMed ID: 8882899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of 4-substituted phenyl alkyl imidazole-based inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
    Patel CH; Dhanani S; Owen CP; Ahmed S
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4752-6. PubMed ID: 16870430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione inhibitors as potential anti-tumour agents.
    Ahmed S; Smith JH; Nicholls PJ; Whomsley R; Cariuk P
    Drug Des Discov; 1995 Apr; 12(4):275-87. PubMed ID: 9040988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of phenyl alkyl imidazole-based compounds as potent inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
    Owen CP; Shahid I; Olusanjo MS; Patel CH; Dhanani S; Ahmed S
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):117-27. PubMed ID: 18620055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
    Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
    J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biochemical evaluation of a range of potent benzyl imidazole-based compounds as potential inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
    Owen CP; Dhanani S; Patel CH; Shahid I; Ahmed S
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4011-5. PubMed ID: 16750362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative cytotoxicity of N-substituted N'-(4-imidazole-ethyl)thiourea in precision-cut rat liver slices.
    Onderwater RC; Commandeur JN; Vermeulen NP
    Toxicology; 2004 Apr; 197(2):81-91. PubMed ID: 15003319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes.
    Laufer SA; Wagner GK; Kotschenreuther DA; Albrecht W
    J Med Chem; 2003 Jul; 46(15):3230-44. PubMed ID: 12852754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of benzimidazole and imidazole compounds as potential aromatase inhibitors.
    Hida F; Robert J; Luu-Duc C
    Farmaco; 1994; 49(7-8):489-92. PubMed ID: 7945714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of the substrate-heme complex approach in the design, synthesis, biochemical evaluation, and rationalization of the inhibitory activity of a range of azole compounds against cholesterol side chain cleavage enzyme.
    Ahmed S
    Biochem Biophys Res Commun; 2000 Aug; 275(1):75-6. PubMed ID: 10944444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, evaluation and QSAR studies of highly potent aromatase inhibitors of the piperidinedione type.
    Baston E; Klein CD; Grimminger W; Hebecker N; Hartmann RW
    Anticancer Drug Des; 2001 Feb; 16(1):37-47. PubMed ID: 11762643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro interaction of dexmedetomidine with human liver microsomal cytochrome P4502D6 (CYP2D6).
    Rodrigues AD; Roberts EM
    Drug Metab Dispos; 1997 May; 25(5):651-5. PubMed ID: 9152607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
    Numazawa M; Kamiyama T; Tachibana M; Oshibe M
    J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of aminoglutethimide: structure/activity relationships and receptor interactions.
    Nicholls PJ; Daly MJ; Smith HJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S55-67. PubMed ID: 3755630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biochemical evaluation of novel inhibitors of aromatase (AR) using an enhanced representation of the active site of AR derived from the consideration of the reaction mechanism.
    Ahmed S; Amanuel Y
    Biochem Biophys Res Commun; 2000 Jan; 267(1):356-61. PubMed ID: 10623624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of the role of the acidic hydrogen in imparting selectivity of 7-(aminosulfonyl)-1,2,3,4-tetrahydroisoquinoline (SK&F 29661) toward inhibition of phenylethanolamine N-methyltransferase vs the alpha 2-adrenoceptor.
    Grunewald GL; Dahanukar VH; Caldwell TM; Criscione KR
    J Med Chem; 1997 Dec; 40(25):3997-4005. PubMed ID: 9406590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aromatase (P450Arom) by some 1-(benzofuran-2-ylmethyl)imidazoles.
    Owen CP; Nicholls PJ; Smith HJ; Whomsley R
    J Pharm Pharmacol; 1999 Apr; 51(4):427-33. PubMed ID: 10385215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase.
    Liverton NJ; Butcher JW; Claiborne CF; Claremon DA; Libby BE; Nguyen KT; Pitzenberger SM; Selnick HG; Smith GR; Tebben A; Vacca JP; Varga SL; Agarwal L; Dancheck K; Forsyth AJ; Fletcher DS; Frantz B; Hanlon WA; Harper CF; Hofsess SJ; Kostura M; Lin J; Luell S; O'Neill EA; O'Keefe SJ
    J Med Chem; 1999 Jun; 42(12):2180-90. PubMed ID: 10377223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.